基因載體市場 - 按載體（質粒DNA、腺相關病毒、逆轉錄病毒）、按應用（基因治療、疫苗學）、按疾病（腫瘤、遺傳、感染）、按終端用戶（CDMO、CRO、製藥和生物技術公司），全球預測2023-2032年

到2032年，全球基因載體市場規模將顯著擴大。臨床試驗數量的成長將為行業成長鋪平道路。許多臨床試驗都在探索聯合療法的潛力，即基因療法與化療、放療或免疫療法等其他治療方式相結合。這些組合方法通常包括使用多種基因載體來提供不同的治療藥物或增強治療的協同作用。臨床試驗中對聯合療法的探索日益增多，促進了對基因載體的更高需求。

整個基因載體市場根據載體、應用、疾病、終端用戶和地區進行分類。

根據載體，慢病毒細分市場的行業佔有率將在2023年至2032年期間以可觀的年複合成長率成長。基因治療領域不斷增加的投資將為該細分市場的成長帶來有利的機會。慢病毒載體廣泛用作向靶細胞傳遞基因的載體。慢病毒載體可有效地將治療基因等遺傳物質轉移到各種細胞類型中，包括非分裂或緩慢分裂的細胞。這種能力使其在基因治療中具有重要價值，可用於治療遺傳性疾病。

基於疾病，從2023年到2032年，傳染病領域的行業佔有率將以顯著的年複合成長率成長。傳染病的日益流行增加了對基因載體的需求。基因載體可用於開發預防傳染性疾病的疫苗。它們可以將特定的抗原基因傳遞到宿主細胞中，引發免疫反應並產生保護性抗體。這種方法的優勢在於能夠產生廣泛的免疫反應，包括細胞免疫，並具有快速開發新發傳染病疫苗的潛力。

根據終端用戶的不同，到2032年，CRO行業的產值將大幅成長。 CRO數量的增加有助於該細分市場的成長。此外，這些機構在開發基因療法方面的努力進一步推動該細分市場的擴張。 CRO利用基因載體進行臨床前研究，以評估潛在基因療法或基於基因的治療方法的安全性和有效性。

從區域來看，2023年至2032年，亞太地區基因載體市場佔有率將以指數級年複合成長率成長。 HIV/AIDS等傳染性疾病的不斷增加增加了該地區對基因載體的需求。此外，快速發展的醫療基礎設施也進一步促進了該地區的成長。根據IBEF的資料，在2023-24年的聯邦預算中，印度政府向衛生和家庭福利部撥款107.6億美元。

目錄

第1章：方法與範圍

第2章：執行摘要

第3章基因載體市場洞察

• 行業生態系統分析
• 行業影響因素
  • 成長驅動力
    • 遺傳疾病、癌症和傳染病發病率上升
    • 更先進的基因編輯技術的發展
    • 個性化醫療需求增加
    • 用於開發基因療法的研發投資增加
    • 對基於病毒載體的基因療法的持續研究
  • 行業陷阱與挑戰
    • 基因治療的高成本
    • 與基因載體開發法規核准相關的挑戰
• 成長潛力分析
  • 按載體類型
  • 按應用
  • 按疾病
  • 按最終用戶
• COVID-19影響分析
• 技術分析
• 監管概況
  • 美國
  • 歐洲
• 波特分析
• PESTEL分析

第4章：2022年競爭格局

• 公司介紹
• 2022年公司矩陣分析
• 2022年市場佔有率分析
• 競爭定位矩陣
• 戰略儀表板

第5章：基因載體市場規模及預測：按載體類型分類

• 按載體類型分類的主要趨勢
• 質粒DNA
• 逆轉錄病毒
• 慢病毒
• 腺病毒
• 腺相關病毒
• 其他載體類型

第6章：基因載體市場規模及預測：按應用分類

• 按應用分類的主要趨勢
• 基因治療
• 疫苗學
• 其他應用

第7章：基因載體市場規模及預測：按疾病分類

• 按疾病分類的主要趨勢
• 腫瘤
• 遺傳性疾病
• 傳染病
• 其他疾病

第8章：基因載體市場規模及預測：按最終用戶分類

• 按最終用戶分類的主要趨勢
• CDMO公司
• 製藥和生物技術公司
• 研究機構
• CRO公司

第9章：基因載體市場規模及預測：按地區分類

• 各地區主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲和紐西蘭
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第10章：公司簡介

• Lonza
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Oxford Biomedica
• Cobra Biologics
• Novasep
• Spark Therapeutics
• Kaneka Eurogentec
• Finvector Vision Therapies
• Brammer Bio
• Cell and Gene Therapy Catapult
• FUJIFILM Diosynth Biotechnologies
• uniQure NV

Global Gene Vector Market size will expand considerably through 2032. Growing number of clinical trials will pave the way for industry growth. Many clinical trials explore the potential of combination therapies, where gene therapy is combined with other treatment modalities such as chemotherapy, radiation therapy, or immunotherapy. These combination approaches often involve the use of multiple gene vectors to deliver different therapeutic agents or enhance treatment synergies. The increasing exploration of combination therapies in clinical trials contributes to the higher demand for gene vectors.

The overall gene vector market is classified based on vector, application, diseases, end-user, and region.

Based on the vector, industry share from the lentiviral segment will grow at a substantial CAGR from 2023 to 2032. Increasing investment in gene therapy will generate lucrative opportunities for segment growth. Lentiviral vectors are widely used as vehicles for delivering genes into target cells. They can efficiently transfer genetic material, such as therapeutic genes, to a range of cell types, including non-dividing or slowly dividing cells. This ability makes them valuable in gene therapy, where they are used to treat genetic disorders.

Based on diseases, industry share from the infectious disease segment will grow at a significant CAGR from 2023 to 2032. Growing prevalence of infectious diseases has increased the demand for gene vectors. Gene vectors can be used to develop vaccines against infectious diseases. They can deliver specific antigen genes into host cells, triggering an immune response and the production of protective antibodies. This approach offers advantages such as the ability to generate a broad immune response, including cellular immunity, and the potential to rapidly develop vaccines for emerging infectious diseases.

Based on the end-user, industry value from the CROs segment will register significant gains through 2032. Increasing number of CROs is contributing to segment growth. Moreover, rising efforts by these organizations toward the development of gene therapies are further creating a notable impetus for segment expansion. CROs conduct preclinical studies using gene vectors to assess the safety and efficacy of potential gene therapies or gene-based treatments.

Regionally, the Asia Pacific gene vector market share will grow at an exponential CAGR from 2023 to 2032. Growing occurrence of infectious disorders such as HIV/AIDS has increased the demand for gene vectors in the region. Moreover, rapidly expanding healthcare infrastructure is further contributing to regional growth. As per IBEF, in the Union Budget 2023-24, the government of India awarded USD 10.76 billion to the Ministry of Health and Family Welfare.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data Sources
  • 1.4.1 Secondary
    • 1.4.1.1 Paid sources
    • 1.4.1.2 Public sources
  • 1.4.2 Primary

Chapter 2 Executive Summary

• 2.1 Gene vector 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Vector type trends
• 2.4 Application trends
• 2.5 Disease trends
• 2.6 End user trends

Chapter 3 Gene Vector Market Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of genetic disorders, cancer, and infectious diseases
    • 3.2.1.2 Development of more advanced gene editing technologies
    • 3.2.1.3 Increasing demand for personalized medicine
    • 3.2.1.4 Increase in R&D investments for the development of gene therapy
    • 3.2.1.5 Ongoing research into viral vector-based gene therapies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of gene therapies
    • 3.2.2.2 Challenges associated with regulatory approval of gene vectors development
• 3.3 Growth potential analysis
  • 3.3.1 By vector type
  • 3.3.2 By application
  • 3.3.3 By disease
  • 3.3.4 By end user
• 3.4 COVID- 19 impact analysis
• 3.5 Technological analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Market share analysis , 2022
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Gene Vector Market Size and Forecast, By Vector Type (USD Million)

• 5.1 Key trends, by vector type
• 5.2 Plasmid DNA
• 5.3 Retroviral
• 5.4 Lentiviral
• 5.5 Adenoviral
• 5.6 Adeno-associated viral
• 5.7 Other vector types

Chapter 6 Gene Vector Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Gene therapy
• 6.3 Vaccinology
• 6.4 Other applications

Chapter 7 Gene Vector Market Size and Forecast, By Disease (USD Million)

• 7.1 Key trends, by disease
• 7.2 Oncology
• 7.3 Genetic disorders
• 7.4 Infectious diseases
• 7.5 Other diseases

Chapter 8 Gene Vector Market Size and Forecast, By End-user (USD Million)

• 8.1 Key trends, by end-user
• 8.2 CDMOs
• 8.3 Pharmaceutical and biotechnology companies
• 8.4 Research institutes
• 8.5 CROs

Chapter 9 Gene Vector Market Size and Forecast, By Region (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia and New Zealand
  • 9.4.5 Rest of Asia pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Lonza
• 10.2 Merck KGaA
• 10.3 Thermo Fisher Scientific Inc.
• 10.4 Oxford Biomedica
• 10.5 Cobra Biologics
• 10.6 Novasep
• 10.7 Spark Therapeutics
• 10.8 Kaneka Eurogentec
• 10.9 Finvector Vision Therapies
• 10.10 Brammer Bio
• 10.11 Cell and Gene Therapy Catapult
• 10.12 FUJIFILM Diosynth Biotechnologies
• 10.13 uniQure N.V.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by vector type (2022)
• TABLE 3 Market revenue, by application (2022)
• TABLE 4 Market share, by disease2022)
• TABLE 5 Market share, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Global gene vector market size, by region, 2018 - 2022 (USD Million)
• TABLE 8 Global gene vector market size, by region, 2023 - 2032 (USD Million)
• TABLE 9 Global gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 10 Global gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 11 Global gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 12 Global gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 13 Global gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 14 Global gene vector market size, by disease 2023 - 2032 (USD Million)
• TABLE 15 Global gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 16 Global gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 17 Industry impact forces
• TABLE 18 Competitive benchmarking of major market players
• TABLE 19 Competitive positioning matrix: classification criteria
• TABLE 20 Strategic outlook matrix: classification criteria
• TABLE 21 Plasmid DNA market size, 2018 - 2022 (USD Million)
• TABLE 22 Plasmid DNA market size, 2023 - 2032 (USD Million)
• TABLE 23 Adenoviral market size, 2018 - 2022 (USD Million)
• TABLE 24 Adenoviral market size, 2023 - 2032 (USD Million)
• TABLE 25 Adeno-associated viral market size, 2018 - 2022 (USD Million)
• TABLE 26 Adeno-associated viral market size, 2023 - 2032 (USD Million)
• TABLE 27 Retroviral market size, 2018 - 2022 (USD Million)
• TABLE 28 Retroviral market size, 2023 - 2032 (USD Million)
• TABLE 29 Lentiviral market size, 2018 - 2022 (USD Million)
• TABLE 30 Lentiviral market size, 2023 - 2032 (USD Million)
• TABLE 31 Other vector types market size, 2018 - 2022 (USD Million)
• TABLE 32 Other vector types market size, 2023 - 2032 (USD Million)
• TABLE 33 Gene therapy market size, 2018 - 2022 (USD Million)
• TABLE 34 Gene therapy market size, 2023 - 2032 (USD Million)
• TABLE 35 Vaccinology market size, 2018 - 2022 (USD Million)
• TABLE 36 Vaccinology market size, 2023 - 2032 (USD Million)
• TABLE 37 Other applications market size, 2018 - 2022 (USD Million)
• TABLE 38 Other applications market size, 2023 - 2032 (USD Million)
• TABLE 39 Oncology market size, 2018 - 2022 (USD Million)
• TABLE 40 Oncology market size, 2023 - 2032 (USD Million)
• TABLE 41 Genetic disorders market size, 2018 - 2022 (USD Million)
• TABLE 42 Genetic disorders market size, 2023 - 2032 (USD Million)
• TABLE 43 Infectious diseases market size, 2018 - 2022 (USD Million)
• TABLE 44 Infectious diseases market size, 2023 - 2032 (USD Million)
• TABLE 45 Other diseases market size, 2018 - 2022 (USD Million)
• TABLE 46 Other diseases market size, 2023 - 2032 (USD Million)
• TABLE 47 CDMOs market size, 2018 - 2022 (USD Million)
• TABLE 48 CDMOs market size, 2023 - 2032 (USD Million)
• TABLE 49 Pharmaceutical and biotechnology companies market size, 2018 - 2022 (USD Million)
• TABLE 50 Pharmaceutical and biotechnology companies market size, 2023 - 2032 (USD Million)
• TABLE 51 Research institutes market size, 2018 - 2022 (USD Million)
• TABLE 52 Research institutes market size, 2023 - 2032 (USD Million)
• TABLE 53 CROs market size, 2018 - 2022 (USD Million)
• TABLE 54 CROs market size, 2023 - 2032 (USD Million)
• TABLE 55 North America gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 56 North America gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 57 North America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 58 North America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 59 North America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 60 North America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 61 North America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 62 North America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 63 North America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 64 North America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 65 U.S. gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 66 U.S. gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 67 U.S. gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 68 U.S. gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 69 U.S. gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 70 U.S. gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 71 U.S. gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 72 U.S. gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 73 Canada gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 74 Canada gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 75 Canada gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 76 Canada gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 77 Canada gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 78 Canada gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 79 Canada gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 80 Canada gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 81 Europe gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 82 Europe gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 83 Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 84 Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 85 Europe gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 86 Europe gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 87 Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 88 Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 89 Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 90 Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 91 Germany gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 92 Germany gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 93 Germany gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 94 Germany gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 95 Germany gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 96 Germany gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 97 Germany gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 98 Germany gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 99 UK gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 100 UK gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 101 UK gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 102 UK gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 103 UK gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 104 UK gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 105 UK gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 106 UK gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 107 France gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 108 France gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 109 France gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 110 France gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 111 France gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 112 France gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 113 France gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 114 France gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 115 Italy gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 116 Italy gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 117 Italy gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 118 Italy gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 119 Italy gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 120 Italy gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 121 Italy gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 122 Italy gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 123 Spain gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 124 Spain gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 125 Spain gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 126 Spain gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 127 Spain gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 128 Spain gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 129 Spain gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 130 Spain gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 131 Rest of Europe gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 132 Rest of Europe gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 133 Rest of Europe gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 134 Rest of Europe gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 135 Rest of Europe gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 136 Rest of Europe gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 137 Rest of Europe gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 138 Rest of Europe gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 139 Asia Pacific gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 140 Asia Pacific gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 141 Asia Pacific gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 142 Asia Pacific gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 143 Asia Pacific gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 144 Asia Pacific gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 145 Asia Pacific gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 146 Asia Pacific gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 147 Asia Pacific gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 148 Asia Pacific gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 149 China gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 150 China gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 151 China gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 152 China gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 153 China gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 154 China gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 155 China gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 156 China gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 157 Japan gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 158 Japan gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 159 Japan gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 160 Japan gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 161 Japan gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 162 Japan gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 163 Japan gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 164 Japan gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 165 India gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 166 India gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 167 India gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 168 India gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 169 India gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 170 India gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 171 India gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 172 India gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 173 Australia & The Newzealand gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 174 Australia & The Newzealand gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 175 Australia & The Newzealand gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 176 Australia & The Newzealand gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 177 Australia & The Newzealand gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 178 Australia & The Newzealand gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 179 Australia & The Newzealand gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 180 Australia & The Newzealand gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 181 Rest of APAC gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 182 Rest of APAC gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 183 Rest of APAC gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 184 Rest of APAC gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 185 Rest of APAC gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 186 Rest of APAC gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 187 Rest of APAC gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 188 Rest of APAC gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 189 Latin America gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 190 Latin America gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 191 Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 192 Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 193 Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 194 Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 195 Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 196 Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 197 Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 198 Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 199 Brazil gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 200 Brazil gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 201 Brazil gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 202 Brazil gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 203 Brazil gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 204 Brazil gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 205 Brazil gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 206 Brazil gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 207 Mexico gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 208 Mexico gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 209 Mexico gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 210 Mexico gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 211 Mexico gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 212 Mexico gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 213 Mexico gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 214 Mexico gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 215 Rest of Latin America gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 216 Rest of Latin America gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 217 Rest of Latin America gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 218 Rest of Latin America gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 219 Rest of Latin America gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 220 Rest of Latin America gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 221 Rest of Latin America gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 222 Rest of Latin America gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 223 Middle East & Africa gene vector Market size, by country, 2018 - 2022 (USD Million)
• TABLE 224 Middle East & Africa gene vector Market size, by country, 2023 - 2032 (USD Million)
• TABLE 225 Middle East & Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 226 Middle East & Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 227 Middle East & Africa gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 228 Middle East & Africa gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 229 Middle East & Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 230 Middle East & Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 231 Middle East & Africa gene vector market size, by end user, 2018 - 2022 (USD Million)
• TABLE 232 Middle East & Africa gene vector market size, by end user, 2023 - 2032 (USD Million)
• TABLE 233 South Africa gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 234 South Africa gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 235 South Africa gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 236 South Africa gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 237 South Africa gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 238 South Africa gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 239 South Africa gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 240 South Africa gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 241 Saudi Arabia gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 242 Saudi Arabia gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 243 Saudi Arabia gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 244 Saudi Arabia gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 245 Saudi Arabia gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 246 Saudi Arabia gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 247 Saudi Arabia gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 248 Saudi Arabia gene vector market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 249 Rest of MEA gene vector market size, by vector type, 2018 - 2022 (USD Million)
• TABLE 250 Rest of MEA gene vector market size, by vector type, 2023 - 2032 (USD Million)
• TABLE 251 Rest of MEA gene vector market size, by application, 2018 - 2022 (USD Million)
• TABLE 252 Rest of MEA gene vector market size, by application, 2023 - 2032 (USD Million)
• TABLE 253 Rest of MEA gene vector market size, by disease, 2018 - 2022 (USD Million)
• TABLE 254 Rest of MEA gene vector market size, by disease, 2023 - 2032 (USD Million)
• TABLE 255 Rest of MEA gene vector market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 256 Rest of MEA gene vector market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Gene vector industry 36 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by vector type
• FIG 8 Growth potential analysis, by application
• FIG 9 Growth potential analysis, by disease
• FIG 10 Growth potential analysis, by end-use
• FIG 11 Porter's analysis
• FIG 12 PESTEL analysis
• FIG 13 Competitive dashboard, 2022
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players, 2022
• FIG 16 Competitive positioning matrix
• FIG 17 Strategic outlook matrix